Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2010
09/08/2010EP1412374B1 Novel pgc-1 isoforms and uses therefor
09/08/2010EP1328662B1 Flea peritrophin nucleic acid molecules, proteins and uses thereof
09/08/2010EP0770132B1 New streptogramines
09/08/2010CN1942581B Antibody with osteoclast-related protein as target
09/08/2010CN1908009B Acetes chinensis protein antigypertensive peptide and preparation method and application thereof
09/08/2010CN101827943A Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof
09/08/2010CN101827937A Novel DNA fragment, recombinant vector containing the same, transformant transformed therewith and utilization of the same
09/08/2010CN101827604A Treatment for anxiety
09/08/2010CN101824458A Method for preparing high-efficiency antioxidant potato protein antioxidant peptide
09/08/2010CN101824457A Method for preparing casein antioxidant peptide by chymosin
09/08/2010CN101824456A Preparation method of antihypertensive active peptide
09/08/2010CN101824455A Soy protein oligopeptide, and preparation method and use thereof
09/08/2010CN101824454A Two-stage preparation technology of high activity casein angiotensin converting enzyme inhibitory peptides
09/08/2010CN101824453A Two-stage preparation technology of high activity casein antioxidant peptides
09/08/2010CN101824452A Batch type feed-batch fermentation method for streptomyces roseosporus to produce Daptomycin efficiently
09/08/2010CN101824451A Glutathione fermentation production method
09/08/2010CN101824435A Expression system of tilapia neuropeptide Y recombinant protein
09/08/2010CN101824428A Method for preparing phycoerythrin-phycocyanin protein alpha subunit fluorescent protein of streptavidin mark combined with phycoerythrobilin through molecular design
09/08/2010CN101824427A Method for preparing phycoerythrin-phycocyanin protein alpha subunit fluorescent protein combined with phycourobilin through molecule design
09/08/2010CN101824426A Method for preparing phycoerythrin-phycocyanin protein alpha subunit fluorescent protein combined with phycoerythrobilin through molecule design
09/08/2010CN101824425A Method for preparing phycoerythrin-phycocyanin protein alpha subunit fluorescent protein of streptavidin mark combined with phycoerythrobilin through molecular design
09/08/2010CN101824406A Recombinant beta-lactamase-RGD-fusion protein and application thereof in medicine
09/08/2010CN101824394A Streptococcus suis II-type subunit vaccine and application thereof
09/08/2010CN101824225A Tussah silk peptide-glutin blend film and preparation method
09/08/2010CN101824091A G-CSF (Granulocyte-Colony Stimulating Factor) fusion protein mutant, preparation method and application thereof
09/08/2010CN101824071A Antioxidant peptide from collagen and application thereof
09/08/2010CN101418271B Bacillus amyloliquefaciens producing lipopeptide to promote fungi apoptosis and lipopeptide prepared by the same and use
09/07/2010US7790961 nucleotide sequence that code an insecticidal protein for resistance against coleopteran pest the corn rootworm
09/07/2010US7790872 Rice catalase B promoter
09/07/2010US7790866 a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, a screening system
09/07/2010US7790864 Antibody to BACE455, an alternative splice variant of the human beta-secretase
09/07/2010US7790863 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
09/07/2010US7790862 IL-17 and IL-23 antagonists and methods of using the same
09/07/2010US7790861 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals
09/07/2010US7790858 Immunoadhesin comprising increased neonatal Fc receptor specificity for use in treatment and prevention of cell proliferative disorders
09/07/2010US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders
09/07/2010US7790696 Cationic liposomes containing immune response generating moieties
09/07/2010US7790682 Use in tissue engineering, tissue repair; stimulating mitogenesis in cells
09/07/2010US7790655 A system for whole antibody cell surface display on mammalian cells to facilitate the rapid identification of antibodies with modified Fc regions having altered effector function
09/07/2010US7790450 Plasmid comprising heat shock promoter 16 for production of heterologous proteins in Schizosaccharomyces pombe; multicloning vector
09/07/2010US7790448 Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene
09/07/2010US7790428 Essential fungal polypeptide, CaYDR341c, and methods of use thereof
09/07/2010US7790426 Sesquiterpene synthases and methods of use
09/07/2010US7790425 Using transgenic trichoderma as bioreactor for production of monoglucuronide degrading enzyme for use in treatment of systemic lupus erythematosus, autoimmune diseases or thrombosis
09/07/2010US7790420 Screening for expression of soluble protein via modification of peptide substrates; novel reporter molecules
09/07/2010US7790416 Using transgenic eschrichia as bioreactor to generate succinic acid under anaerobic conditions
09/07/2010US7790415 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents
09/07/2010US7790414 Methods for producing antibodies
09/07/2010US7790413 Capable synthesising mono-, bi- and/or tri-cyclic sesquiterpenes having a C2-C7 or a C3-C7 bond, via farnesyl-pyrophosphate precursor; for catalyzing cyclisation to the santalene and bergamotene carbon skeletons
09/07/2010US7790412 Membrane proteins; yeasts; baculovirus cells
09/07/2010US7790411 Everninomicin biosynthetic genes
09/07/2010US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
09/07/2010US7790187 Recombinant granule antigen protein (GRA6) for use in diagnosis, prevention and treatment of parasitic infection
09/07/2010US7790186 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine
09/07/2010US7790185 Bacterial mutant for generating bacterial toxins for use in developing vaccine against infections; cultivating Bordetella pertussis bacteria that lack cysteine desulfinase activity by knocking out Bordetella pertussis cysteine desulfinase gene, whereby an enhanced amount of PT is produced
09/07/2010US7790174 G-CSF polypeptides and uses thereof
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010CA2596274C Recombinant mva virus, and the use thereof
09/07/2010CA2507664C Novel neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product
09/07/2010CA2450871C Assay for identifying inhibitors of hiv rt dimerization
09/02/2010WO2010099394A1 Alteration and modulation of protein activity by varying post-translational modification
09/02/2010WO2010099153A2 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
09/02/2010WO2010098863A1 Humanized platelet activating factor antibody design using anti-lipid antibody templates
09/02/2010WO2010098861A1 Reengineering mrna primary structure for enhanced protein production
09/02/2010WO2010098471A1 Immunization method using cancer cell
09/02/2010WO2010098421A1 Recombinant human bone morphogenetic protein having improved storage stability
09/02/2010US20100222557 Cytokine zalpha11ligand antibodies
09/02/2010US20100222553 Spider silk dragline polynucleotides, polypeptides and methods of use thereof
09/02/2010US20100222429 Enzymatic Methods and Enzymes
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222267 Recombinant transferrin mutants
09/02/2010US20100222266 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
09/02/2010US20100222237 Methods for Generating Polynucleotides Having Desired Characteristics by Iterative Selection and Recombination
09/02/2010US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/02/2010US20100221783 Expression Cloning Method Suitable for Selecting Library Clones Producing a Polypeptide of Interest
09/02/2010US20100221782 Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties
09/02/2010US20100221781 Cho-k1 cell line
09/02/2010US20100221780 comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs; has a greater trypsin inhibitory activity
09/02/2010US20100221779 Phytases, nucleic acids encoding them and methods for making and using them
09/02/2010US20100221778 Novel lignin-resistant cellulase enzymes
09/02/2010US20100221777 Designer ligands of tgf-beta superfamily
09/02/2010US20100221776 Process for the Fermentative Production of Heterologous Proteins by Means of Escherichia Coli
09/02/2010US20100221775 Increased production of secreted proteins by recombinant eukaryotic cells
09/02/2010US20100221774 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus E1A protein, and proteins obtained thereby
09/02/2010US20100221773 Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof
09/02/2010US20100221724 Patched polypeptides and uses related thereto
09/02/2010US20100221385 Asparaginases
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221280 Plant-produced compositions for treating papillomavirus infection and related methods
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/02/2010US20100221262 Anti-unc5b antibodies and methods of use
09/02/2010US20100221257 Binding members-513
09/02/2010US20100221256 Meningococcus adhesins nada, app and orf 40
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221222 Interferons, uses and compositions related thereto
09/02/2010US20100221183 Peptides for treating and diagnosing cancers and methods for using the same
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 1125